Active substanceGlycineGlycine Similar drugsTo uncover Glycine pills n / az. BIOTICS MNPK, LLC Russia Glycine pills n / az. VERTEKS, AO Russia Glycine forte pills n / az. CANONFARMA PRODUCTION, CJSC Russia Glycine Fort Pharmaplant® pills n / az. Pharmaplant Fabrication Chemistry Product GmbH Germany Glycine-Bio Pharmaplant® pills n / az. OZONE, LLC Russia Glycine-Canon pills n / az. CANONFARMA PRODUCTION, CJSC Russia Glycine-MCPP pills n / az. MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC Russia Dosage form: & nbsptablets cheek Composition:1 the tablet contains: active substance: glycine 1000 mg; Excipients: aspartame, copovidone (kollidone VA-64 or plasdon Es-630), croscarmellose sodium (impellose), magnesium stearate, sorbitol (sorbitol). Description:Round, biconvex tablets white or almost white, with a cruciform risk. Allowed a slight marbling. Pharmacotherapeutic group:Metabolic means ATX: & nbspN.06.B.X Other psychostimulants and nootropic drugs Pharmacodynamics:A replaceable amino acid, the central neurotransmitter of the inhibitory type of action. It improves the metabolic processes in the brain tissues, has an antidepressant and sedative effect. Has glycinergic, antioxidant and antitoxic action; regulates the activity of glutamate receptors, due to which it reduces psychoemotional stress,aggression and conflict; improves adaptation and mood; facilitates sleep and normalizes sleep; increases mental performance; reduces the severity of vegetative-vascular disorders (including in the climacteric period) and cerebral disorders in ischemic stroke and craniocerebral trauma, the toxic effect of ethanol on the central nervous system. Pharmacokinetics:Easily penetrates into most biological fluids and body tissues, incl. in the brain, do not cumulate. Rapidly destroyed in the liver by glycine oxidase to water and carbon dioxide. Indications:Ischemic stroke (as part of complex therapy). Contraindications:Hypersensitivity, fructose intolerance and glucose / galactose absorption disorder or sugarase / isomaltase insufficiency, hemorrhagic insult, children's atozraart. (effectivelyfromthe and security not atfromtaMr.aboutoweus). Carefully:Arterial hypotension. Pregnancy and lactation:The drug is contraindicated during pregnancy and lactation due to the lack of sufficient data. Dosing and Administration:In ischemic stroke: during the first 3-6 hours after development, 1000 mg (1 tablet) is given once, buccally, then for 1-5 days, 1/4 tablet 4 times a day, then for the next 30 days, 1/4 tablet 3 times a day. The maximum daily dose is 1000 mg. Side effects:Allergic reactions. Overdose:Not described. Interaction:It reduces the severity of side effects of antipsychotic drugs (antipsychotics), anxiolytics, antidepressants, hypnotics and anticonvulsant drugs. Effect on the ability to drive transp. cf. and fur:Care should be taken when driving vehicles and engaging in other potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions, taking into account the profile of side effects. Form release / dosage:Bleaching tablets, 1000 mg. Packaging:For 5 or 10 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered. 1, 2, 4 contour cell packs of 5 tablets or 1.2 contour cell packs of 10 tablets together with instructions for use are placedin a pack of cardboard. Storage conditions:In dry, the dark place at a temperature of no higher than 25 ° C. Keep out of the reach of children. Shelf life:2 years. Do not use after the expiration date. Terms of leave from pharmacies:On prescription Registration number:LSR-008972/10 Date of registration:31.08.2010 Expiration Date:Unlimited The owner of the registration certificate:CANONFARMA PRODUCTION, CJSC CANONFARMA PRODUCTION, CJSC Russia Manufacturer: & nbspCANONFARMA PRODUCTION, CJSC Russia Representation: & nbspCANONFARMA PRODUCTION CJSC CANONFARMA PRODUCTION CJSC Russia Information update date: & nbsp01.05.2017 Illustrated instructions × Illustrated instructions Instructions